Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The roles of cathelicidin LL-37 in immune defences and novel clinical applications.
Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
Analysis of CD4+CD8+ double positive T cells in blood, cerebrospinal fluid and multiple sclerosis lesions.
The validity and reliability of the neurogenic bladder symptom score (NBSS).
The pathology of multiple sclerosis.
Development of nucleic acid drugs for neurological disorders.
Influence of treatments in multiple sclerosis disability: A cohort study.
Secukinumab: first global approval.
Multiple sclerosis and glutamate excitotoxicity.
Minoderm
The role of interleukin-6 signaling in nervous tissue.
A combination trial of estriol plus glatiramer acetate in relapsing-remitting multiple sclerosis: effect on disabilities
Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis.
Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive.
Neuromyelitis optica in a patient with pemphigus foliaceus.
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
Humoral mechanisms in T cell vaccination: induction and functional characterization of anti-lymphocytic autoantibodies.
Animal assisted interventions in neurorehabilitation: A review of the most recent literature.
Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis. (MOBILE)
Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis.
Transient gadolinium leakage in natalizumab-treated multiple sclerosis.
Correction: quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.
Consensus statements from a panel of u.s. Managed care pharmacists and physicians for management of multiple sclerosis agents.
Balance exercise for persons with multiple sclerosis using Wii games: a randomised, controlled multi-centre study.
[Physical rehabilitation in multiple sclerosis: general principles and high-tech approaches].
Pages
« first
‹ previous
…
170
171
172
173
174
175
176
177
178
…
next ›
last »